28th week of 2018 patent applcation highlights part 8 |
Patent application number | Title | Published |
20180193271 | AN ORAL PHARMACEUTICAL DOSAGE FORM FOR THE DELIVERY OF A PEPTIDE AND/OR PROTEIN | 2018-07-12 |
20180193272 | ORAL DELIVERY PRODUCT | 2018-07-12 |
20180193273 | PHARMACEUTICAL COMPOSITION COMPRISING AMLODIPINE AND DEXTROMETHORPHAN | 2018-07-12 |
20180193274 | COMPOSITIONS FOR ILEO-JEJUNAL DRUG DELIVERY | 2018-07-12 |
20180193276 | DOSAGE FORMS OF HALOFUGINONE AND METHODS OF USE | 2018-07-12 |
20180193277 | GAMMA-HYDROXYBUTYRIC ACID GRANULES | 2018-07-12 |
20180193278 | METHOD OF SYNTHESIS OF SILICA VESICLES AND USE THEREOF | 2018-07-12 |
20180193279 | NOVEL DIESTER AND TRIESTER BASED LOW MOLECULAR WEIGHT, BIODEGRADEABLE CATIONIC LIPIDS FOR OLIGONUCLEOTIDE DELIVERY | 2018-07-12 |
20180193280 | Process and Apparatuses For Preparing Nanoparticle Compositions with Amphiphilic Copolymers and Their Use | 2018-07-12 |
20180193281 | COMPOSITION AND METHODS OF TREATMENT | 2018-07-12 |
20180193282 | IMPLANTABLE DRUG DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF | 2018-07-12 |
20180193283 | TRANSDERMAL THERAPEUTIC SYSTEM CONTAINING ASENAPINE | 2018-07-12 |
20180193284 | TRANSDERMAL CREAM CONTAINING IMMUNOMODULATORS AND IMIQUIMOD | 2018-07-12 |
20180193285 | Rivastigmine Transdermal Compositions and Methods of Using the Same | 2018-07-12 |
20180193286 | COMPOSITIONS COMPRISING A DENDRIMER-RESVERATROL COMPLEX AND METHODS FOR MAKING AND USING THE SAME | 2018-07-12 |
20180193287 | HOPS-BASED SUBSTANCE AND USE OF THE SUBSTANCE | 2018-07-12 |
20180193288 | METHODS AND COMPOSITIONS FOR TREATING SYMPTOMS ASSOCIATED WITH POST-TRAUMATIC STRESS DISORDER USING CYCLOBENZAPRINE | 2018-07-12 |
20180193289 | PROTOTYPICAL MOLECULAR PHARMACOLOGIC PROFILE OF FENDILINE AGAINSTNEURODEGENERATIVE AND NEURODEVELOPMENTAL DISEASES | 2018-07-12 |
20180193290 | TAPENTADOL NASAL COMPOSITION | 2018-07-12 |
20180193291 | FORMULATIONS COMPRISING 2-AMINO-2-[2-(4-OCTYLPHENYL)ETHYL]PROPANE-1,3-DIOL | 2018-07-12 |
20180193292 | PROCESS FOR PREPARATION OF CYSTEAMINE BITARTRATE | 2018-07-12 |
20180193293 | FATTY ACID AMIDES FOR THE PREVENTION AND/OR TREATMENT OF STEATOHEPATITIS | 2018-07-12 |
20180193294 | Dehydroabietic acid (DHAA) derivatives for use as ion channel openers | 2018-07-12 |
20180193295 | GABA AGONISTS IN THE TREATMENT OF DISORDERS ASSOCIATED WITH METABOLIC SYNDROME AND GABA COMBINATIONS IN TREATMENT OR PROPHYLAXIS OF TYPE I DIABETES | 2018-07-12 |
20180193296 | LTB4 INHIBITION TO PREVENT AND TREAT HUMAN LYMPHEDEMA | 2018-07-12 |
20180193297 | ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS FOR USE AS MEDICINES | 2018-07-12 |
20180193298 | COMPOSITION CONTAINING DIHOMO-GAMMA-LINOLENIC ACID (DGLA) AS THE ACTIVE INGREDIENT | 2018-07-12 |
20180193299 | ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN | 2018-07-12 |
20180193300 | GLYCERYL 3-HYDROXYBUTYRATES FOR TRAUMATIC BRAIN INJURY | 2018-07-12 |
20180193301 | Lactylates for the prevention and treatment of infections caused by gram-positive bacteria in animals | 2018-07-12 |
20180193302 | Ultra Low Dose Doxepin And Methods Of Using The Same To Treat Sleep Disorders | 2018-07-12 |
20180193303 | NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS | 2018-07-12 |
20180193304 | PHYTOTERPENOID FACILITATION OF THERAPEUTIC ONSET AND EFFICACY OF SUBLINGUAL CANNABINOID ADMINISTRATION | 2018-07-12 |
20180193305 | CROMOLYN COMPOSITIONS FOR TREATMENT OF CHRONIC COUGH DUE TO IDIOPATHIC PULMONARY FIBROSIS | 2018-07-12 |
20180193306 | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCULAR DISORDERS AND BONE DISORDERS | 2018-07-12 |
20180193307 | METHODS TO MITIGATE INJURY FROM RADIATION EXPOSURE | 2018-07-12 |
20180193308 | POLYMORPHIC FORMS OF ST-246 AND METHODS OF PREPARATION | 2018-07-12 |
20180193309 | USE OF INDOLE COMPOUNDS FOR FAT REDUCTION AND SKIN AND SOFT TISSUE TIGHTENING | 2018-07-12 |
20180193310 | QUORUM SENSING INHIBITORS FOR BIOFILM INHIBITION | 2018-07-12 |
20180193311 | SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS | 2018-07-12 |
20180193312 | NUTRACEUTICAL COMPOSITION AND DOSING REGIMEN | 2018-07-12 |
20180193313 | GLUCOCORTICOID RECEPTOR MODULATORS TO TREAT PANCREATIC CANCER | 2018-07-12 |
20180193314 | AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES | 2018-07-12 |
20180193315 | SPIROCYCLIC HAT INHIBITORS AND METHODS FOR THEIR USE | 2018-07-12 |
20180193316 | DRUG COMPOSITIONS | 2018-07-12 |
20180193317 | Angiotensin II Receptor Antagonist for the Prevention or Treatment of Systemic Diseases in Cats | 2018-07-12 |
20180193318 | NOVEL METHODS FOR TREATING CANCER | 2018-07-12 |
20180193319 | REGIMEN FOR SUPPRESSING ORGAN REJECTION | 2018-07-12 |
20180193320 | ANYHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE | 2018-07-12 |
20180193321 | INDOLOTRYPTOLINE ANTICANCER AGENTS | 2018-07-12 |
20180193322 | THIENOPYRIDINE DERIVATIVE FOR THE TREATMENT OF HEPATITIS C INFECTIONS | 2018-07-12 |
20180193323 | THIAZOLECARBOXAMIDES AND PYRIDINECARBOXAMIDE COMPOUNDS USEFUL AS PIM KINASE INHIBITORS | 2018-07-12 |
20180193324 | USE OF EP4 RECEPTOR ANTAGONISTS IN THE TREATMENT OF CARTILAGE DISEASE | 2018-07-12 |
20180193325 | METHODS FOR THE TREATMENT OF NEUROLOGICAL DISORDERS | 2018-07-12 |
20180193326 | OPHTHALMIC COMPOSITION | 2018-07-12 |
20180193327 | PROPHYLACTIC LEUKOTRIENE INHIBITOR AND IMPLANT DISPLACEMENT THERAPY FOR PREVENTION AND TREATMENT OF CAPSULAR CONTRACTURE IN SILICONE BREAST AUGMENTATION | 2018-07-12 |
20180193328 | USE OF LAQUINIMOD TO DELAY HUNTINGTON'S DISEASE PROGRESSION | 2018-07-12 |
20180193329 | METHODS OF TREATING CANCER PATIENTS WITH FARNESYLTRANSFERASE INHIBITORS | 2018-07-12 |
20180193330 | ALKYLATED TETRAHYDROISOQUINOLINES FOR BINDING TO CENTRAL NERVOUS SYSTEM RECEPTORS | 2018-07-12 |
20180193333 | TRANSDERMAL DELIVERY SYSTEM | 2018-07-12 |
20180193334 | PHARMACEUTICAL COMPOSITION OF VORTIOXETINE OR SALT THEREOF, AND PREPARATION METHOD THEREFOR | 2018-07-12 |
20180193335 | COMPOSITIONS, FORMULATIONS, PACKAGED PHARMACEUTICALS, AND METHODS OF USING HEDGEHOG PATHWAY MODULATORS FOR THE SENSITIZATION OF RESISTANT TUMORS | 2018-07-12 |
20180193336 | SPRAY DRY FORMULATIONS | 2018-07-12 |
20180193337 | Methods of Blocking the CXCR-4/SDF-1 Signaling Pathway With Inhibitors of Bruton's Tyrosine Kinase | 2018-07-12 |
20180193338 | NEPRILYSIN INHIBITORS | 2018-07-12 |
20180193339 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING DRY EYE DISEASES, CONTAINING IMATINIB AS ACTIVE INGREDIENT | 2018-07-12 |
20180193341 | DNA-PK INHIBITORS | 2018-07-12 |
20180193342 | COMBINATION THERAPY FOR TREATMENT OF HEMATOLOGICAL CANCERS AND SOLID TUMORS | 2018-07-12 |
20180193343 | IMIDAZO-PYRAZINYL DERIVATIVES USEFUL AS SOLUBLE GUANYLATE CYCLASE ACTIVATORS | 2018-07-12 |
20180193344 | Nanocarriers And Their Processing For Diagnostics And Therapeutics | 2018-07-12 |
20180193345 | INHIBITORS OF BRUTON'S TYROSINE KINASE FOR THE TREATMENT OF SOLID TUMORS | 2018-07-12 |
20180193346 | PHARMACEUTICAL COMBINATIONS | 2018-07-12 |
20180193347 | TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS | 2018-07-12 |
20180193348 | Medicament for Treating Peripheral Neuropathies | 2018-07-12 |
20180193349 | USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES FOR TREATING LYMPHOMAS | 2018-07-12 |
20180193350 | TREATMENT OF NUT MIDLINE CARCINOMA | 2018-07-12 |
20180193351 | Form C of Avibactam Sodium | 2018-07-12 |
20180193352 | HETEROARYLDIAZEPINE DERIVATIVES AS RSV INHIBITORS | 2018-07-12 |
20180193353 | Method of Treating or Preventing Pathologic Effects of Acute Increases in Hyperglycemia and/or Acute Increases of Free Fatty Acid Flux | 2018-07-12 |
20180193354 | TREATMENT OF MIGRAINES | 2018-07-12 |
20180193355 | APPLICATIONS FOR ESTRONE IN PREPARING ANTI-OVARIAN CANCER AND/OR BREAST CANCER PRODUCTS | 2018-07-12 |
20180193356 | METHODS AND COMPOSITIONS FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS | 2018-07-12 |
20180193357 | ANTICONVULSANT ACTIVITY OF STEROIDS | 2018-07-12 |
20180193358 | DERMATOLOGICAL COMPOSITIONS AND METHODS | 2018-07-12 |
20180193359 | CHEMICAL ENTITIES THAT KILL SENESCENT CELLS FOR USE IN TREATING AGE-RELATED DISEASE | 2018-07-12 |
20180193360 | Dihydrotestosterone and Dihydrotestosterone Derivatives and Promoters in the Treatment of Cancer | 2018-07-12 |
20180193361 | GUT ANTI-INFLAMMATORY AGENTS FOR REGULATION OF HIGH BLOOD GLUCOSE LEVELS | 2018-07-12 |
20180193362 | GLUTAMINE ANTAGONISTS FOR THE TREATMENT OF COGNITIVE DEFICITS AND PSYCHIATRIC DISORDERS | 2018-07-12 |
20180193363 | METHODS AND COMPOSITIONS FOR PROTECTION OF CELLS AND TISSUES FROM COMPUTED TOMOGRAPHY RADIATION | 2018-07-12 |
20180193364 | USE OF ZOLEDRONIC ACID TO PREPARE DRUG TREATING FATTY LIVER DISEASE | 2018-07-12 |
20180193365 | USE OF HYDROGEN SULFIDE TO PREVENT LENS OPACIFICATION | 2018-07-12 |
20180193366 | INHIBITION OF HIV INFECTION THROUGH CHEMOPROPHYLAXIS | 2018-07-12 |
20180193367 | METHOD FOR PROLONGING THE OVER SURVIVAL OF A CANCER PATIENT | 2018-07-12 |
20180193368 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | 2018-07-12 |
20180193369 | METHOD FOR TREATING OR PREVENTING DRY EYES | 2018-07-12 |
20180193370 | Dosage Regimen for a Tiacumicin Compound | 2018-07-12 |
20180193371 | IMMUNOSTIMULATING OLIGONUCLEOTIDE COMPLEX | 2018-07-12 |
20180193372 | NOVEL BIOMARKER FOR DIAGNOSING RESISTANCE TO ANTICANCER AGENT FOR BILLARY TRACT CANCER AND USE THEREOF | 2018-07-12 |
20180193373 | Method for Preparing Linseed Polysaccharide Having Antiviral Activity and Immunological Activity, and Use of the Linseed Polysaccharide | 2018-07-12 |
20180193374 | MICRO-RNA FOR THE TREATMENT OF MALIGNANT SOLID TUMORS AND METASTASIS | 2018-07-12 |